LU70852A1 - - Google Patents

Info

Publication number
LU70852A1
LU70852A1 LU70852A LU70852A LU70852A1 LU 70852 A1 LU70852 A1 LU 70852A1 LU 70852 A LU70852 A LU 70852A LU 70852 A LU70852 A LU 70852A LU 70852 A1 LU70852 A1 LU 70852A1
Authority
LU
Luxembourg
Application number
LU70852A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE7312001A external-priority patent/SE382047B/xx
Application filed filed Critical
Publication of LU70852A1 publication Critical patent/LU70852A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
LU70852A 1973-09-04 1974-09-04 LU70852A1 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7312001A SE382047B (sv) 1973-09-04 1973-09-04 Forfarande for framstellning av 4-aminoamfetaminderivat

Publications (1)

Publication Number Publication Date
LU70852A1 true LU70852A1 (ja) 1975-06-11

Family

ID=20318423

Family Applications (1)

Application Number Title Priority Date Filing Date
LU70852A LU70852A1 (ja) 1973-09-04 1974-09-04

Country Status (16)

Country Link
US (1) US3996381A (ja)
JP (1) JPS5835177B2 (ja)
AT (1) AT336566B (ja)
BE (1) BE819515A (ja)
CA (1) CA1051436A (ja)
CH (2) CH603547A5 (ja)
DE (1) DE2440734C2 (ja)
DK (1) DK139716B (ja)
FI (1) FI62281C (ja)
FR (1) FR2242079B1 (ja)
GB (1) GB1461667A (ja)
HK (1) HK75778A (ja)
IE (1) IE40514B1 (ja)
LU (1) LU70852A1 (ja)
NL (1) NL7411753A (ja)
NO (2) NO139408C (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030232890A1 (en) * 2000-11-01 2003-12-18 Sention, Inc. Methods for treating an impairment in memory consolidation
US7619005B2 (en) * 2000-11-01 2009-11-17 Cognition Pharmaceuticals Llc Methods for treating cognitive impairment in humans with Multiple Sclerosis
JP2004534724A (ja) * 2000-11-01 2004-11-18 センション，インコーポレイテッド 記憶固化を調節するための方法および組成物
US20050059743A1 (en) * 2000-11-01 2005-03-17 Sention, Inc. Methods for treating mild cognitive impairment and alzheimer's disease
US20030119884A1 (en) * 2000-11-01 2003-06-26 Epstein Mel H. Methods and compositions for regulating memory consolidation
US20070117869A1 (en) * 2000-11-01 2007-05-24 Cognition Pharmaceuticals Llc Methods for treating coginitive impairment and improving cognition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3117160A (en) * 1961-07-27 1964-01-07 Pfizer & Co C Aralkylamines
US3496195A (en) * 1966-05-11 1970-02-17 Chinoin Gyogyszer Es Vegyeszet D-o-bromo-phenyl-isopropyl-methylpropinylamine and its salts

Also Published As

Publication number Publication date
BE819515A (fr) 1975-03-04
HK75778A (en) 1979-01-05
FR2242079A1 (ja) 1975-03-28
GB1461667A (en) 1977-01-19
FI257674A7 (ja) 1975-03-05
DK464774A (ja) 1975-05-05
CH599106A5 (ja) 1978-05-12
FR2242079B1 (ja) 1978-07-21
AU7283374A (en) 1976-03-04
DE2440734C2 (de) 1985-01-24
FI62281B (fi) 1982-08-31
ATA702574A (de) 1976-09-15
NO139408C (no) 1979-03-07
NO142624B (no) 1980-06-09
JPS5050329A (ja) 1975-05-06
US3996381A (en) 1976-12-07
CH603547A5 (ja) 1978-08-31
NL7411753A (nl) 1975-03-06
NO743177L (ja) 1975-04-01
CA1051436A (en) 1979-03-27
DK139716C (ja) 1979-09-17
FI62281C (fi) 1982-12-10
NO791507L (no) 1975-03-05
IE40514B1 (en) 1979-06-20
IE40514L (en) 1975-03-04
DK139716B (da) 1979-04-02
NO139408B (no) 1978-11-27
JPS5835177B2 (ja) 1983-08-01
AT336566B (de) 1977-05-10
NO142624C (no) 1980-09-17
DE2440734A1 (de) 1975-03-13

Similar Documents

Publication Publication Date Title
AU476761B2 (ja)
AU474593B2 (ja)
AU474511B2 (ja)
AU476714B2 (ja)
DK139716C (ja)
AU472848B2 (ja)
AU477823B2 (ja)
AU476873B1 (ja)
AU477824B2 (ja)
AU447540B2 (ja)
AU471461B2 (ja)
AU1891376A (ja)
CH153575A4 (ja)
AU479539A (ja)
CH560351A5 (ja)
CH487073A4 (ja)
CH561572A5 (ja)
CH562972A5 (ja)
CH1070074A4 (ja)
BG21371A3 (ja)
BG19868A2 (ja)
CH564380A5 (ja)
BG19676A1 (ja)
BG19551A1 (ja)
BG19441A1 (ja)